Get the Stockscreener App
0.4424
1.03%
-0.0046
After Hours:
.44
-0.0024
-0.54%
Tilray Brands Inc stock is traded at $0.4424, with a volume of 14.58M.
It is down -1.03% in the last 24 hours and up +0.48% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
See More
Previous Close:
$0.447
Open:
$0.44
24h Volume:
14.58M
Relative Volume:
0.52
Market Cap:
$453.69M
Revenue:
$829.22M
Net Income/Loss:
$-248.96M
P/E Ratio:
-1.4747
EPS:
-0.3
Net Cash Flow:
$-92.10M
1W Performance:
-10.63%
1M Performance:
+0.48%
6M Performance:
-66.99%
1Y Performance:
-75.83%
1-Day Range:
$0.426
$0.4434
1-Week Range:
$0.426
$0.489
52-Week Range:
$0.4138
$2.15
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
0.4424 | 502.88M | 829.22M | -248.96M | -92.10M | -0.30 |
|
HLN
Haleon Plc Adr
|
11.14 | 48.63B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
162.58 | 72.59B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.84 | 3.27M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.57 | 44.08B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.96 | 19.43B | 16.54B | -1.64B | 749.00M | -1.45 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Tilray (NASDAQ:TLRY) Stock Price Down 2.2%What's Next? - MarketBeat
Tilray Brands (TSE:TLRY) Stock Price Down 7.4%Should You Sell? - MarketBeat
Tilray Inc (NASDAQ:TLRY) Stock Holdings Lifted by Tidal Investments LLC - MarketBeat
This Week In Cannabis: DEA Slams Legal Weed, Texas Votes Hemp Ban, Argentina Tightens Medical Rules And More - Benzinga
Tilray (NASDAQ:TLRY) Trading 1.6% HigherShould You Buy? - MarketBeat
Tilray (NASDAQ:TLRY) Trading Down 0.2%Should You Sell? - MarketBeat
What's Going On With Tilray Brands Stock On Thursday? - Benzinga
Tilray Launches Good Supply Cannabis Brand to Germany - marketscreener.com
Introducing Y'all's Beer: A True Taste of Texas from Revolver Brewing - GlobeNewswire
Tilray Expands Beer Portfolio: New Texas-Style Lager Targets $8.5B Southwest Market - Stock Titan
Tilray (TLRY) Expands Good Supply Cannabis Brand into Germany | TLRY Stock News - GuruFocus
Tilray Medical Launches Good Supply Brand in Germany to Enhance Access to Medical Cannabis - Nasdaq
Tilray Medical Brings Canada’s Iconic Cannabis Brand Good Supply to Germany - GlobeNewswire
Tilray (NASDAQ:TLRY) Stock Price Up 1.5%Still a Buy? - MarketBeat
Jefferies Distributor Survey Part 2: Outlook for A-B, Constellation, Molson Coors, Tilray and More - Brewbound
Tilray (NASDAQ:TLRY) Shares Down 6.9%Should You Sell? - MarketBeat
Tilray (NASDAQ:TLRY) Shares Down 4.4%Time to Sell? - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Up 4.5%Should You Buy? - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Down 2.1%Here's Why - MarketBeat
Tilray Brands (NasdaqGS:TLRY) Plans Reverse Stock Split - Yahoo Finance
Dimensional Fund Advisors LP Purchases 769,569 Shares of Tilray Inc (NASDAQ:TLRY) - MarketBeat
Tilray (NASDAQ:TLRY) Shares Up 1.2%Should You Buy? - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Down 1.4%Here's What Happened - MarketBeat
Tilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles - GlobeNewswire
What's Going On With Tilray Brands Stock On Wednesday? - Benzinga
Tilray (TLRY) Unveils New XMG Atomic Sours Cannabis Product Line - GuruFocus
(TLRY) Market Insights and Trading Signals (TLRY:CA) - news.stocktradersdaily.com
Tilray (TLRY) Unveils New XMG Atomic Sours Cannabis Product Line | TLRY Stock News - GuruFocus
2 Stocks Near Their 52-Week Lows That Still Aren't Worth Buying - MSN
Tilray (NASDAQ:TLRY) Trading Down 2.1%What's Next? - MarketBeat
7 Best Marijuana Stocks and ETFs to Buy in 2025 - Money/ US News
Tilray (NASDAQ:TLRY) Trading 2.6% HigherHere's Why - MarketBeat
1 Beaten-Down Stock-Split Company to Avoid in 2025 and Beyond - AOL.com
THC drinks are flying off shelves. Can it last? - AOL.com
Tilray (NASDAQ:TLRY) Trading Up 1.5%Time to Buy? - MarketBeat
Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold? - Zacks Investment Research
Shock Top: A Bold Rebrand for a Craft Beer Icon - GlobeNewswire
Tilray Brands Stock Is Trading at Its All-Time Low. Is It Worth Buying? - AOL.com
Tilray Brands Stock (TLRY): Evaluating New Launch Impact - Value The Markets
Tilray (NASDAQ:TLRY) Trading Down 1%What's Next? - MarketBeat
Blue Point Brewing Co. Announces the Return of Delayed Pilsner - GlobeNewswire
Tilray (NASDAQ:TLRY) Stock Price Down 3.3%Here's Why - MarketBeat
What's Going On With Tilray Brands Stock On Tuesday? - Benzinga
Best Cannabis Stocks To Follow TodayMay 5th - MarketBeat
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tilray Brands Inc Stock (TLRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Persofsky Renah | Director |
Nov 08 '24 |
Option Exercise |
1.50 |
11,958 |
17,937 |
75,348 |
| SIMON IRWIN D | President and CEO |
Jul 31 '24 |
Option Exercise |
2.03 |
706,214 |
1,433,614 |
3,637,021 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
703,412 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
468,218 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
583,643 |
| SIMON IRWIN D | President and CEO |
Jul 26 '24 |
Option Exercise |
1.83 |
98,194 |
179,695 |
2,985,109 |
| Merton Carl A | Chief Financial Officer |
Jul 26 '24 |
Option Exercise |
1.83 |
12,166 |
22,264 |
615,102 |
| Looney Thomas P. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
230,038 |
| Hopkinson David G. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
211,185 |
| Herhalt Johann Michael | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
180,514 |
2.47%
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):